Cite

HARVARD Citation

    Luft, T. et al. (n.d.). Response Signature to the CD95-Ligand Inhibitor Asunercept Involve Low Serum P53 and Rankl. Leukemia research. pp. S120-S121. [Online]. 
  
Back to record